CAPN3 and Duchenne muscular dystrophy: Using mass spectrometry to obtain proteomic profiles, distinct proteomic signatures were obtained, corresponding with previous studies performed with patient biopsies or animal models of Duchenne muscular dystrophy and LGMD2A.